Literature DB >> 11175877

Genetic enhancement of inflammatory pain by forebrain NR2B overexpression.

F Wei1, G D Wang, G A Kerchner, S J Kim, H M Xu, Z F Chen, M Zhuo.   

Abstract

N-methyl-D-aspartate (NMDA) receptors contribute to many brain functions. We studied the effect of forebrain-targeted overexpression of the NMDA receptor subunit NR2B on the response of mice to tissue injury and inflammation. Transgenic mice exhibited prominent NR2B expression and enhanced NMDA receptor-mediated synaptic responses in two pain-related forebrain areas, the anterior cingulate cortex and insular cortex, but not in the spinal cord. Although transgenic and wild type mice were indistinguishable in tests of acute pain, transgenic mice exhibited enhanced responsiveness to peripheral injection of two inflammatory stimuli, formalin and complete Freund's adjuvant. Genetic modification of forebrain NMDA receptors can therefore influence pain perception, which suggests that forebrain-selective NMDA receptor antagonists, including NR2B-selective agents, may be useful analgesics for persistent pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175877     DOI: 10.1038/83993

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  97 in total

1.  The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

Authors:  Karla P Zeitz; Nicolas Guy; Annika B Malmberg; Sahera Dirajlal; William J Martin; Linda Sun; Douglas W Bonhaus; Cheryl L Stucky; David Julius; Allan I Basbaum
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Spatiotemporal pattern of concurrent spinal and supraspinal NF-κB expression after peripheral nerve injury.

Authors:  Chiu-Wen Chou; Gordon T C Wong; Grewo Lim; Shuxing Wang; Michael G Irwin; Jianren Mao
Journal:  J Pain       Date:  2010-05-26       Impact factor: 5.820

3.  Cognition-enhancing drugs.

Authors:  Maxwell J Mehlman
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 4.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

5.  Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors.

Authors:  Rashna Balsara; Neill Li; Danielle Weber-Adrian; Louxiu Huang; Francis J Castellino
Journal:  Neuropharmacology       Date:  2012-01-27       Impact factor: 5.250

6.  Enhanced presynaptic neurotransmitter release in the anterior cingulate cortex of mice with chronic pain.

Authors:  Ming-Gao Zhao; Shanelle W Ko; Long-Jun Wu; Hiroki Toyoda; Hui Xu; Jessica Quan; Jianguo Li; Yongheng Jia; Ming Ren; Zao C Xu; Min Zhuo
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

7.  Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain.

Authors:  Alexia E Metz; Hau-Jie Yau; Maria Virginia Centeno; A Vania Apkarian; Marco Martina
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

8.  Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice.

Authors:  Cruz M Cendán; José M Pujalte; Enrique Portillo-Salido; José M Baeyens
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

9.  NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.

Authors:  Cai Xiao; Yuanyuan Huang; Mingxin Dong; Jie Hu; Shuangshuang Hou; Francis J Castellino; Mary Prorok; Qiuyun Dai
Journal:  Neuropeptides       Date:  2008-11-07       Impact factor: 3.286

Review 10.  Ethical, legal, social, and policy implications of behavioral genetics.

Authors:  Colleen M Berryessa; Mildred K Cho
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-02-28       Impact factor: 8.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.